YBL-Vega

Animal-Free Antibody Discovery Platform

YBL-Vega Antibody Discovery Platform

Accelerate your IVD and biopharma programs with YBL-Vega, a 100% animal-free antibody phage-display platform. Rapidly discover high-affinity VHH binders for challenging targets in weeks, not months.

Precision-Engineered Binders. Zero Ethical Constraints.

Collapse your development timelines from months to weeks using our superior synthetic VHH phage-display library.

Book Technical Consultation View Application Data

Why Choose YBL-Vega?

100% Animal-Free Discovery
Eliminate immunization delays and ethical limitations.
Rapid Discovery Cycles
Move from target to lead candidates within 8-10 weeks.
Massive Library Diversity
Access >3×10⁸ independent clones across multiple CDR3 lengths.
Targets the Untargetable
Effective for toxic, non-immunogenic, or structurally complex antigens.

YBL-Vega VHH Advantages

Superior Tissue Penetration
Small molecular size (13-15 kDa) enables deeper epitope access.
Exceptional Stability
High thermal and pH tolerance ensures longer shelf life.
Flexible Antibody Engineering
Convert easily to VHH-Fc, bivalent, or bispecific formats.

YBL-Vega Process Flow